Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

PubMed  Google Scholar 

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.

Article  PubMed  PubMed Central  Google Scholar 

Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86(3):747–803.

Article  CAS  PubMed  Google Scholar 

Ager EI, Neo J, Christophi C. The renin–angiotensin system and malignancy. Carcinogenesis. 2008;29(9):1675–84.

Article  CAS  PubMed  Google Scholar 

George AJ, Thomas WG, Hannan RD. The renin–angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer. 2010;10(11):745–59.

Article  CAS  PubMed  Google Scholar 

Carl-McGrath S, Ebert MPA, Lendeckel U, Rocken C. Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread. Cancer Biol Ther. 2007;6(8):1229–37.

Article  Google Scholar 

Kinoshita J, Fushida S, Harada S, Yagi Y, Fujita H, Kinami S, et al. Local angiotensin II-generation in human gastric cancer: Correlation with tumor progression through the activation of ERK1/2, NF-κB and survivin. Int J Oncol. 2009;34(6):1573–82.

Article  CAS  PubMed  Google Scholar 

Röcken C, Röhl FW, Diebler E, Lendeckel U, Pross M, Carl-McGrath S, et al. The Angiotensin II/Angiotensin II Receptor System Correlates with Nodal Spread in Intestinal Type Gastric Cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1206–12.

Huang MM, Guo AB, Sun JF, Chen XL, Yin ZY. Angiotensin II promotes the progression of human gastric cancer. Mol Med Rep. 2014;9(3):1056–60.

Wang L, Cai S rong, Zhang C hua, He Y long, Zhan W hua, Wu H, et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model. Chin Med J. 2008;121(21):2167.

Okazaki M, Fushida S, Harada S, Tsukada T, Kinoshita J, Oyama K, et al. The Angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer. Cancer Lett. 2014;355(1):46–53.

Fujita N, Fujita K, Iwama H, Kobara H, Fujihara S, Chiyo T, et al. Antihypertensive drug telmisartan suppresses the proliferation of gastric cancer cells in vitro and in vivo. Oncol Rep. 2020;44(1):339–48.

Hallersund P, Elfvin A, Helander HF, Fändriks L. The expression of renin-angiotensin system components in the human gastric mucosa. J Renin Angiotensin Aldosterone Syst. 2011;12(1):54–64.

Article  CAS  PubMed  Google Scholar 

Sugimoto M, Ohno T, Yamaoka Y. Expression of angiotensin II type 1 and type 2 receptor mRNAs in the gastric mucosa of Helicobacter pylori-infected Mongolian gerbils. J Gastroenterol. 2011;46(10):1177–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ender F, Labancz T, Rosivall L. Protective effects of the inhibition of the renin-angiotensin system against gastric mucosal lesions induced by cold-restraint in the rat. Acta Physiol Hung. 1993;81(1):13–8.

CAS  PubMed  Google Scholar 

Bregonzio C, Armando I, Ando H, Jezova M, Baiardi G, Saavedra JM. Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am J Physiol Gastrointest Liver Physiol. 2003;285(2):G414–23.

Article  CAS  PubMed  Google Scholar 

Griniatsos J, Trafalis D. Differences in gastric cancer surgery outcome between East and West: differences in surgery or different diseases? J BUON. 2018;23(5):1210–5.

PubMed  Google Scholar 

Aaltonen P, Mustonen H, Peltola K, Carpén O, Puolakkainen P, Haglund C, et al. The impact of implementing current treatment modalities and female sex on gastric cancer outcomes, 2000–2016: a longitudinal nationwide cohort study. Acta Oncol. 2023;62(12):1732–41.

Article  PubMed  Google Scholar 

Nomesco N. NOMESCO classification of Surgical Procedures (NCSP), version 1.16 [Internet]. 2011 [cited 2024 May 8]. Available from: https://urn.kb.se/resolve?urn=urn:nbn:se:norden:org:diva-4605

WHO ATC/DDD Index [Internet]. [cited 2024 May 6]. Available from: https://atcddd.fhi.no/atc_ddd_index/

Siltari A, Auvinen A, Murtola TJ. Pharmacoepidemiological evaluation in prostate cancer—common pitfalls and how to avoid them. Cancers (Basel). 2021;13(4):696.

Article  CAS  PubMed  Google Scholar 

Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry: experience in Finland. Acta Oncol. 1994;33(4):365–9.

Article  CAS  PubMed  Google Scholar 

Lunkka P, Malila N, Ryynänen H, Heikkinen S, Sallinen V, Koskenvuo L. Accuracy of Finnish cancer registry colorectal cancer data: a comparison between registry data and clinical records. Scand J Gastroenterol. 2021;56(3):247–51.

Article  PubMed  Google Scholar 

Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

Article  CAS  PubMed  Google Scholar 

Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.

Article  PubMed  Google Scholar 

Pylväläinen J, Talala K, Murtola T, Taari K, Raitanen J, Tammela TL, et al. Charlson comorbidity index based on hospital episode statistics performs adequately in predicting mortality, but its discriminative ability diminishes over time. Clin Epidemiol. 2019;11:923–32.

Article  PubMed  PubMed Central  Google Scholar 

Simon R, Makuch RW. A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias. Stat Med. 1984;3(1):35–44.

Article  CAS  PubMed  Google Scholar 

van der Kaaij RT, Koemans WJ, van Putten M, Snaebjornsson P, Luijten JCHBM, van Dieren JM, et al. A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015. Eur J Cancer. 2020;130:23–31.

Article  PubMed  Google Scholar 

Busby J, McMenamin Ú, Spence A, Johnston BT, Hughes C, Cardwell CR. Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study. Aliment Pharmacol Ther. 2018;47(2):279–88.

Article  CAS  PubMed  Google Scholar 

Cui Y, Wen W, Zheng T, Li H, Gao YT, Cai H, et al. Use of antihypertensive medications and survival rates for breast, colorectal, lung, or stomach cancer. Am J Epidemiol. 2019;188(8):1512–28.

Article  PubMed  PubMed Central  Google Scholar 

Li PC, Huang RY, Yang YC, Hsieh KP, Yang YH. Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension—a real-world study. BMC Cancer. 2022;22(1):430.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ishikane S, Takahashi-Yanaga F. The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasis. Biochem Pharmacol. 2018;1(151):96–103.

Article  Google Scholar 

Röcken C, Lendeckel U, Dierkes J, Westphal S, Carl-McGrath S, Peters B, et al. The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin Cancer Res. 2005;11(7):2526–30.

Article  PubMed  Google Scholar 

Cavaleiro-Pinto M, Peleteiro B, Lunet N, Barros H. Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control. 2011;22(3):375–87.

PubMed  Google Scholar 

Mukaisho K-I, Nakayama T, Hagiwara T, Hattori T, Sugihara H. Two distinct etiologies of gastric cardia adenocarcinoma: interactions among pH, Helicobacter pylori, and bile acids. Front Microbiol. 2015;6:412.

Article  PubMed  PubMed Central  Google Scholar 

Wang X, Sweigert P, Eguia E, Varsnik MA, Renz CR, Terrasse WA, et al. Impact of angiotensin system inhibitors on esophageal cancer survival. Surg Open Sci. 2020;16(3):34–8.

Google Scholar 

Maharjan U, Kauppila JH. Gastric cancer completeness in Finnish Cancer Registry and Finnish patient registry: a population-based nationwide retrospective cohort study. BMJ Open. 2022;12(4):e056320.

Article  PubMed  PubMed Central  Google Scholar 

Sund R. Quality of the Finnish Hospital discharge register: a systematic review. Scand J Public Health. 2012;40(6):505–15.

Article  PubMed  Google Scholar